Duke ALS Clinic multi-disciplinary team identifies specific ALS symptoms and problems and provides a wide range of options for dealing with them.
From left: Amylyx Co-founders and Co-CEOs Justin Klee and Josh Cohen/Courtesy Amylyx . The FDA’s Peripheral and Central Nervous System Drugs Advisory Committee will face its first big test since the regulator went against its vote on Biogen’s Aduhelm (aducanumab), approving the still-controversial Alzheimer’s drug in June 2021. On Wednesday, the Committee will vote on […]
You can listen to this and many ALSUntangled podcasts here https://www1.rarediseasesnetwork.org/cms/create/CReATe-Podcasts
Today we celebrated the 50th Anniversary of punk rock in America Today we celebrated the 50th Anniversary of punk rock in America
The NEALS Consortium will be hosting a series of virtual Investigator-focused workshops throughout the spring of 2022. The “Trials of the Future: What COVID Made Us Learn” series will include topics such as trial design adaptations, experiences in current remote trials, home measures, and the state of fluid biomarkers. April 8th, 2022 12:30pm – 1:30pm […]
The Duke ALS Clinic team enjoyed seeing so many friends in person again at the Triangle Walk To Defeat ALS this year
Hope to see you there https://secure2.convio.net/alsa/site/TR/Walks/NorthCarolina?pg=entry&fr_id=14915 Your participation in the Walk to Defeat ALS has a direct impact on people living with ALS and their families at the local level. Through education, support groups, access to care and advocacy, we are working to defeat ALS and provide hope to people living with ALS and their families.
